Global Gene Therapy Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026

MarketResearch.biz delivers in-depth insights on the global gene therapy market in its upcoming report titled, “Global Gene Therapy Market Trends, Applications, Analysis, Growth, and Forecast: 2017 to 2026”. The global gene therapy market is estimated to register a CAGR of X.X% in terms of value during forecast period 2017–2026. The report offers in-depth insights, revenue details, and other vital information regarding the target market, and the various trends, drivers, restraints, opportunities, and threats till 2026. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global gene therapy market report has been segmented on the basis of vector type, gene type, application, and region.

Gene therapy is a technique in which genes with the capacity to prevent or treatment of diseases. In gene therapy a normal gene is inserted into genome to replace an abnormal, disease causing gene. This therapy is used to eliminate cancerous cells, prevent cardiovascular diseases, block neurological disorders, and even eliminate infectious pathogens. Basically there are two type of gene therapy, somatic cell gene therapy and reproductive or germ-line gene therapy. Techniques used to deliver gene therapy are ex-vivo and in-vivo. Gene therapy is still in its initial stage and is expected to hold promising opportunities for the treatment of many diseases.

Major factor expected to drive growth of the global gene therapy market is increasing incidences of chronic diseases among individuals such as lung cancer, liver cancer, brain tumor, prostate cancer, etc. In addition, increasing government initiatives pertaining to gene therapy for treatment of Fanconi’s anemia and Gaucher disease is expected to support growth of the global gene therapy market.

However, high cost of treatment is a major factor expected to restrain growth of the global gene therapy market. In addition, short term benefits to patient for certain diseases such as cystic fibrosis and ADA deficiency is another factor expected to challenge growth of the global gene therapy market over the next few years.

North America market is expected to dominate in the global gene therapy market with higher market share when compared to other regional markets, and is expected to continue its dominance during the forecast period. This can be attributed to increasing patient of cancer, well developed healthcare sector, and favorable medical reimbursement policies. Europe market accounts for second-largest revenue share in the global gene therapy market followed by markets in Asia Pacific, Latin America and Middle East & Africa respectively. The market in Asia Pacific is projected to witness fastest growth in terms of revenue, owing to increasing government initiatives for development of healthcare sector, and presence of prominent players operating in this region.

Global Gene Therapy Market Segmentation:

By Vector:

• Viral vector
  • Retroviruses
  • Lentiviruses
  • Adenoviruses
  • Adeno Associated Virus
  • Herpes Simplex Virus
  • Poxvirus
  • Vaccinia Virus
• Non-viral vector
  • Naked/Plasmid Vectors
  • Gene Gun
  • Electroporation
  • Lipofection

By Gene Therapy:

• Antigen
• Cytokine
• Tumor Suppressor
• Suicide
• Deficiency
• Growth factors
• Receptors
• Other

By Application:

• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious disease
• Other Diseases

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Novartis, Kite Pharma, Inc.
• GlaxoSmithKline PLC
• Spark Therapeutics Inc.
• Bluebird bio Inc.
• Genethon
• Transgene SA
• Applied Genetic Technologies Corporation
• Oxford BioMedica PLC
• NewLink Genetics Corp.
• Amgen Inc.